There are provided the compounds of formula I and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of AML.Linvention porte sur des composés de formule (I) et sur des sels pharmaceutiquement acceptables de ceux-ci, ainsi que sur les compositions pharmaceutiques contenant lesdits composés et leurs sels pharmaceutiquement acceptables, et sur lutilisation desdits composés et desdites compositions pharmaceutiques pour le traitement, le contrôle ou lamélioration dAML.
